Novo Nordisk Sues Pfizer Over Insulin Patent

Law360, New York (August 2, 2006, 12:00 AM EDT) -- Hoping to block its rival from getting a leg up in the lucrative insulin market, drug maker Novo Nordisk A/S has smacked Pfizer Inc. with an infringement suit, claiming that its inhalable insulin product Exubera tramples upon the Danish company’s patents.

Novo Nordisk brought the suit in the U.S. District Court for the Southern District of New York on Tuesday, alleging Pfizer infringed five of its patents related to an insulin treatment for diabetes. The company said it will also seek a preliminary injunction against Pfizer...
To view the full article, register now.